Your browser doesn't support javascript.
loading
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
McMahon, Meagan; O'Dell, George; Tan, Jessica; Sárközy, András; Vadovics, Máté; Carreño, Juan Manuel; Puente-Massaguer, Eduard; Muramatsu, Hiromi; Bajusz, Csaba; Rijnink, Willemijn; Beattie, Mitchell; Tam, Ying K; Kirkpatrick Roubidoux, Ericka; Francisco, Isabel; Strohmeier, Shirin; Kanekiyo, Masaru; Graham, Barney S; Krammer, Florian; Pardi, Norbert.
Afiliación
  • McMahon M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • O'Dell G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Tan J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Sárközy A; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Vadovics M; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Carreño JM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Puente-Massaguer E; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Muramatsu H; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Bajusz C; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Rijnink W; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Beattie M; Biotechnological National Laboratory, Institute of Genetics, Biological Research Centre, Szeged 6726, Hungary.
  • Tam YK; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Kirkpatrick Roubidoux E; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
  • Francisco I; Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
  • Strohmeier S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Kanekiyo M; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Graham BS; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Pardi N; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A ; 119(45): e2206333119, 2022 11 08.
Article en En | MEDLINE | ID: mdl-36322769
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Infecciones por Orthomyxoviridae / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Infecciones por Orthomyxoviridae / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article